Only amyloidogenic intermediates of transthyretin induce apoptosis

Biochem Biophys Res Commun. 2002 Jun 7;294(2):309-14. doi: 10.1016/S0006-291X(02)00465-5.

Abstract

In diseases like Alzheimer's disease and familial amyloidotic polyneuropathy (FAP) amyloid deposits co-localize with areas of neurodegeneration. FAP is associated with mutations of the plasma protein transthyretin (TTR). We can here show an apoptotic effect of amyloidogenic mutants of TTR on a human neuroblastoma cell line. Toxicity could be blocked by catalase indicating a free oxygen radical dependent mechanism. The toxic effect was dependent on the state of aggregation and unexpectedly mature fibrils from FAP-patients who failed to exert an apoptotic response. Morphological studies revealed a correlation between toxicity and the presence of immature amyloid. Thus, we can show that toxicity is associated with early stages of fibril formation and propose that mature full-length fibrils represent an inert end stage, which might serve as a rescue mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism
  • Amyloid Neuropathies, Familial / genetics
  • Amyloid Neuropathies, Familial / metabolism*
  • Amyloid beta-Peptides / metabolism*
  • Amyloid beta-Peptides / toxicity
  • Apoptosis* / drug effects
  • Catalase / pharmacology
  • Cytoprotection / drug effects
  • Dose-Response Relationship, Drug
  • Humans
  • In Situ Nick-End Labeling
  • Mutagenesis, Site-Directed
  • Neuroblastoma / metabolism*
  • Neuroblastoma / pathology
  • Peptide Fragments / metabolism*
  • Peptide Fragments / toxicity
  • Prealbumin / genetics
  • Prealbumin / toxicity*
  • Prealbumin / ultrastructure
  • Protein Binding / physiology
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • Prealbumin
  • amyloid beta-protein (1-40)
  • Catalase